Dr. Ahmed Farhan
For many years, fatty liver disease was considered a problem confined to the liver. Patients were often reassured that it was “just a little fat in the liver” or were told that simply avoiding alcohol or reducing dietary fat would solve the problem.
We now know that this view is outdated.
Modern research has fundamentally changed our understanding of fatty liver disease. In recognition of its metabolic origins, the international liver community has renamed nonalcoholic fatty liver disease (NAFLD) as metabolic dysfunction-associated steatotic liver disease (MASLD).
This change is more than a new name—it reflects an entirely new understanding of the disease.
MASLD is not merely a disorder of fat accumulation within the liver. It is a manifestation of widespread metabolic dysfunction that affects nearly every major organ system.
The liver serves as the body’s metabolic headquarters, regulating glucose metabolism, cholesterol production, fat processing, hormone metabolism, detoxification, and nutrient storage.
When fat begins to accumulate within liver cells, it is often a sign that these metabolic processes are becoming overwhelmed.
For this reason, MASLD should be viewed as an early warning signal—not an isolated liver disease.
Here are six of the most important medical conditions closely associated with fatty liver disease.
1. Metabolic Syndrome
Among all conditions associated with MASLD, none is more closely linked than metabolic syndrome.
Rather than representing a single disease, metabolic syndrome is a cluster of metabolic abnormalities that dramatically increases the risk of cardiovascular disease, type 2 diabetes, chronic kidney disease, and premature death.
A diagnosis is generally made when an individual has at least three of the following:
- Increased waist circumference (abdominal obesity)
- Elevated blood pressure
- Elevated fasting blood glucose
- High triglyceride levels
- Low HDL (“good”) cholesterol
These abnormalities share one common underlying mechanism—insulin resistance.
When the body becomes resistant to insulin, excess glucose is converted into fat within the liver, resulting in hepatic steatosis. As liver fat increases, insulin resistance worsens, creating a vicious metabolic cycle.
Many hepatologists now consider MASLD to be the hepatic manifestation of metabolic syndrome rather than an independent disease.
In many patients, a diagnosis of fatty liver is the first visible sign that metabolic syndrome has already begun.
2. Type 2 Diabetes
Few diseases have a stronger relationship with MASLD than type 2 diabetes.
Studies estimate that approximately 70% of individuals with type 2 diabetes also have fatty liver disease, while patients with MASLD have a substantially increased risk of developing diabetes over time.
The relationship is bidirectional.
How Diabetes Promotes Fatty Liver
In insulin resistance, the pancreas compensates by producing increasing amounts of insulin.
Persistently elevated insulin stimulates the liver to convert excess carbohydrates into triglycerides, promoting fat accumulation within liver cells.
How Fatty Liver Worsens Diabetes
A fatty, inflamed liver becomes less responsive to insulin.
Instead of appropriately storing glucose, the liver continues releasing glucose into the bloodstream, making blood sugar more difficult to control.
As a result, MASLD and type 2 diabetes accelerate each other’s progression, increasing the likelihood of developing metabolic dysfunction-associated steatohepatitis (MASH), liver fibrosis, and cirrhosis.
3. Cardiovascular Disease
Although MASLD is a liver disease, heart disease—not liver failure—is the leading cause of death among people with fatty liver disease.
This finding surprises many patients.
The liver plays a central role in regulating cholesterol and triglyceride metabolism.
When excess fat accumulates inside the liver:
- LDL (“bad”) cholesterol increases
- Triglycerides rise
- HDL (“good”) cholesterol often decreases
At the same time, fatty liver releases inflammatory molecules into the bloodstream that damage blood vessels and accelerate atherosclerosis.
Over time, this chronic inflammation contributes to narrowing and hardening of the arteries, substantially increasing the risk of:
- Coronary artery disease
- Heart attack
- Ischemic stroke
- Peripheral artery disease
- Atrial fibrillation
For this reason, managing MASLD is as much about protecting the heart as it is about protecting the liver.
4. Polycystic Ovary Syndrome (PCOS)
Polycystic ovary syndrome (PCOS) is one of the most common hormonal disorders affecting women of reproductive age.
Beyond its reproductive manifestations, PCOS is fundamentally a metabolic disorder.
Many women with PCOS develop:
- Insulin resistance
- Central obesity
- Elevated triglycerides
- Prediabetes
- Type 2 diabetes
These same metabolic abnormalities drive fat accumulation within the liver.
Research consistently demonstrates that women with PCOS are significantly more likely to develop MASLD than women without PCOS, even at younger ages.
Elevated insulin stimulates ovarian androgen production while simultaneously promoting liver fat accumulation.
Because of this shared metabolic pathway, women with PCOS should be considered at increased risk for fatty liver disease and may benefit from early metabolic evaluation and liver screening.
5. Obstructive Sleep Apnea
Obstructive sleep apnea (OSA) is increasingly recognized as an important contributor to fatty liver disease.
OSA causes repeated episodes of airway obstruction during sleep, resulting in intermittent oxygen deprivation.
This nightly cycle of hypoxia triggers:
- Oxidative stress
- Systemic inflammation
- Insulin resistance
- Increased fat accumulation within the liver
Clinical studies have shown that untreated sleep apnea is associated not only with the development of MASLD but also with more rapid progression to MASH and liver fibrosis.
Patients who have obesity, loud snoring, excessive daytime sleepiness, or witnessed pauses in breathing during sleep should be evaluated for obstructive sleep apnea as part of comprehensive metabolic care.
6. Hypothyroidism
Thyroid hormones regulate the body’s metabolic rate.
When thyroid hormone levels decline, virtually every aspect of metabolism slows—including fat metabolism.
Hypothyroidism contributes to:
- Elevated LDL cholesterol
- Increased triglycerides
- Weight gain
- Reduced energy expenditure
- Increased insulin resistance
These metabolic disturbances promote fat accumulation inside the liver.
Although hypothyroidism alone does not cause MASLD, it significantly increases susceptibility, particularly when combined with obesity or metabolic syndrome.
Correctly diagnosing and treating thyroid disease can improve overall metabolic health and may contribute to better liver outcomes.
Why These Conditions Occur Together
The common thread linking MASLD with these diseases is insulin resistance and chronic low-grade inflammation.
Rather than affecting a single organ, metabolic dysfunction simultaneously impacts the liver, pancreas, blood vessels, heart, ovaries, thyroid, muscles, and adipose tissue.
Fatty liver is therefore best understood as a visible marker of systemic metabolic disease rather than an isolated abnormality detected on ultrasound.
The Bottom Line
Metabolic dysfunction-associated steatotic liver disease should never be dismissed as an incidental imaging finding or a benign accumulation of liver fat. It is a powerful indicator that the body’s metabolic machinery is under strain and that multiple organ systems may already be affected.
The encouraging news is that MASLD is often reversible, particularly in its early stages. Sustainable weight loss, regular physical activity, a Mediterranean-style diet, optimal diabetes management, treatment of sleep apnea and hypothyroidism when present, and aggressive control of cardiovascular risk factors can substantially reduce liver fat and improve long-term health.
When you treat fatty liver disease, you are doing far more than protecting your liver. You are lowering your risk of heart disease, improving insulin sensitivity, reducing the likelihood of type 2 diabetes, preserving hormonal health, and investing in healthier aging.
A healthy liver is not simply a sign of good liver function—it is a reflection of good metabolic health.
